Home Tags New Product/Service Testing

Tag: New Product/Service Testing

First Pill for Postpartum Depression Is Approved by FDA
BUSINESS News

First Pill for Postpartum Depression Is Approved by FDA

HS -
0
FDA Approves GSK’s RSV Vaccine for Older Adults
BUSINESS News

FDA Approves GSK’s RSV Vaccine for Older Adults

HS -
0
Moderna, Merck Show Progress Toward Cancer Vaccines
BUSINESS News

Moderna, Merck Show Progress Toward Cancer Vaccines

HS -
0
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
BUSINESS News

Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults

HS -
0
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
BUSINESS News

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

HS -
0
Alzheimer’s Drug Slows Disease Progression in Trial
BUSINESS News

Alzheimer’s Drug Slows Disease Progression in Trial

HS -
0
Sanofi, Glaxo Seek Covid-19 Vaccine Approval in Crowded Market
BUSINESS News

Sanofi, Glaxo Seek Covid-19 Vaccine Approval in Crowded Market

HS -
0
FDA Rejects Short Sellers’ Request to Halt Trials of Alzheimer’s Drug
BUSINESS News

FDA Rejects Short Sellers’ Request to Halt Trials of Alzheimer’s Drug

HS -
0
Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
BUSINESS News

Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients

HS -
0
Pfizer to Ask Regulators to Authorize Covid-19 Vaccine Booster
BUSINESS News

Pfizer to Ask Regulators to Authorize Covid-19 Vaccine Booster

HS -
0
FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns
BUSINESS News

FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns

HS -
0
CureVac Shares Plunge Premarket on Disappointing Covid-19 Vaccine Trial
BUSINESS News

CureVac Shares Plunge Premarket on Disappointing Covid-19 Vaccine Trial

HS -
0
Pair of Covid-19 Drugs Performed Well in Studies, Makers Say
BUSINESS News

Pair of Covid-19 Drugs Performed Well in Studies, Makers Say

HS -
0
AstraZeneca Releases Covid-19 Vaccine Data Showing 76% Efficacy
BUSINESS News

AstraZeneca Releases Covid-19 Vaccine Data Showing 76% Efficacy

HS -
0
U.S. Health Officials Raise Concerns Over AstraZeneca Vaccine Data
BUSINESS News

U.S. Health Officials Raise Concerns Over AstraZeneca Vaccine Data

HS -
0
AstraZeneca’s Covid-19 Vaccine Is Safe, 79% Effective in Late-Stage U.S. Trials
BUSINESS News

AstraZeneca’s Covid-19 Vaccine Is Safe, 79% Effective in Late-Stage U.S. Trials

HS -
0
Lilly Alzheimer’s Drug Shows Modest Benefit in Clinical Trial
BUSINESS News

Lilly Alzheimer’s Drug Shows Modest Benefit in Clinical Trial

HS -
0
Drugmakers Look for New Ways to Test Covid-19 Vaccines
BUSINESS News

Drugmakers Look for New Ways to Test Covid-19 Vaccines

HS -
0
Johnson & Johnson Asks U.S. Regulators for Emergency Approval of Its Covid-19 Vaccine
BUSINESS News

Johnson & Johnson Asks U.S. Regulators for Emergency Approval of Its Covid-19 Vaccine

HS -
0
© Newspaper WordPress Theme by TagDiv